Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Stover

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Brain, Behavior, and Immunity|October 8, 2022
Typhoid vaccine does not impact feelings of social connection or social behavior in a randomized crossover trial among middle-aged female breast cancer survivorsAnnelise A Madison, Baldwin Way, Kyle G Ratner, et al.
JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Cancers|September 9, 2023
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer SurvivorshipAnnelise A Madison, Rebecca Andridge, Anthony H Kantaras, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
Journal of Neuro-Oncology|September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional reportVaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.
NAR Cancer|June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy responseKevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Brain, Behavior, and Immunity|October 8, 2022
Typhoid vaccine does not impact feelings of social connection or social behavior in a randomized crossover trial among middle-aged female breast cancer survivorsAnnelise A Madison, Baldwin Way, Kyle G Ratner, et al.
JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Cancers|September 9, 2023
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer SurvivorshipAnnelise A Madison, Rebecca Andridge, Anthony H Kantaras, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
Journal of Neuro-Oncology|September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional reportVaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.
NAR Cancer|June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy responseKevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
Pageof 15